US2006142351A1PendingUtilityA1
Method of increasing systemic tryptophan with niacin compounds
Est. expiryJun 30, 2020(expired)· nominal 20-yr term from priority
Inventors:Michael F. Murray
A61K 31/70A61K 31/44
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Chronic infection with retroviruses, such as HIV, induce a number of metabolic derangements. The present invention relates to a method for increasing systemic tryptophan with niacin compounds.
Claims
exact text as granted — not AI-modified1 . A method of increasing systemic tryptophan comprising the administration of an effective amount of niacin for increasing systemic tryptophan to a patient in need of an increase in systemic tryptophan wherein the patient is infected with a retrovirus and wherein the patient has a diet that includes at least the RDA (recommended daily allowance) of niacin and tryptophan, wherein the effective amount is approximately 100 milligrams per day.
2 . The method of increasing systemic tryptophan in claim 1 wherein the effective amount is approximately 500 milligrams per day.
3 . A method of increasing systemic tryptophan comprising the administration of an effective amount of niacin to a patient in need of an increase in systemic tryptophan wherein the effective amount is at least 100 milligrams per day.
4 . The method of increasing systemic tryptophan in claim 3 wherein the effective amount is at least 500 milligrams per day.
5 . A method of increasing systemic tryptophan comprising the administration of a pharmacological dose of niacin to a patient in need of an increase in systemic tryptophan wherein the pharmacological dose is at least 100 milligrams per day.
6 . The method of increasing systemic tryptophan in claim 5 wherein the pharmacological dose is at least 500 milligrams per day.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.